FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

703802001: Acquired angioedema due to C1 inhibitor autoantibody (disorder)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3009860016 Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3009869015 Acquired angioedema due to the presence of neutralizing antibodies against C1 inhibitor. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3009158015 Acquired angio-oedema due to C1 inhibitor autoantibody en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3009454012 Acquired angioedema due to C1 inhibitor autoantibody (disorder) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3009619014 Acquired angioedema due to C1 inhibitor autoantibody en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5956171000241112 angiœdème acquis dû à des autoanticorps anti C1 fr Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5956181000241114 angiœdème acquis dû à des autoanticorps inhibiteurs de C1 fr Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. Is a A rare non-histaminic angioedema characterised by potentially life-threatening episodes of oedema of subcutaneous and/or mucosal tissues without urticaria, caused by excessive consumption of C1 esterase inhibitor (C1-INH) in the context of lymphoproliferative or autoimmune diseases. Patients typically present in the fourth decade of life or later and without a family history of angioedema. Clinical manifestation includes nonpitting oedema of the skin predominantly involving the face, but also the limbs or genitals, as well as abdominal pain due to involvement of the gastrointestinal mucosa and severe oedema of the upper airway and oral mucosa. Laboratory examination shows low C1-INH activity and low C3, C4, and C1q levels. Autoantibodies to C1-INH are frequently detectable. true Inferred relationship Some
Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. Associated morphology A raised, erythematous papule or cutaneous plaque, usually representing short-lived dermal edema. false Inferred relationship Some 2
Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. Occurrence Adulthood false Inferred relationship Some 1
Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. Associated morphology Angioedema true Inferred relationship Some 1
Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. Occurrence Any period of life commencing after birth, but before death. true Inferred relationship Some 1
Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. Is a Autoimmune angioedema (disorder) true Inferred relationship Some
Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. Pathological process (attribute) Autoimmune process true Inferred relationship Some 1
Acquired angio-oedema due to the presence of neutralising antibodies against C1 inhibitor. Causative agent (attribute) Kallidin I true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start